IMAAVY 185 mg/mL
nipocalimab-aahu · INJECTION, SOLUTION, CONCENTRATE · Janssen Biotech, Inc.
IMAAVY is a injection, solution, concentrate containing nipocalimab-aahu at 185 mg/mL, taken intravenous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- IMAAVY
- Generic Name
- nipocalimab-aahu
- NDC Code (Product)
57894-801- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 185 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761430
- Marketing Start
- 04/29/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is IMAAVY used for?
IMAAVY contains nipocalimab-aahu. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is IMAAVY a controlled substance?
IMAAVY is not classified as a controlled substance by the DEA.
What is the generic name for IMAAVY?
The generic name for IMAAVY is nipocalimab-aahu. There are no other listed brand versions of nipocalimab-aahu.
What is the NDC code for IMAAVY 185 mg/mL?
The NDC (National Drug Code) for IMAAVY 185 mg/mL is 57894-801, listed by Janssen Biotech, Inc..
Other IMAAVY Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)